Skip to content

Clinical trials

Terminated Phase 1/2 Primary Myelofibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Phase: Phase 1/2 Status: Terminated Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20153
20162
20192
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation4
Asana BioSciences1
Astex Pharmaceuticals, Inc.1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Novartis Pharmaceuticals1
Ohio State University Comprehensive Cancer Center1
Suzhou Zelgen Biopharmaceuticals Co.,Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis10
Myelodysplastic Syndromes6
Myeloproliferative Disorders5
Leukemia, Myeloid, Acute4
Lymphoma4
Leukemia3
Lymphoma, Large B-Cell, Diffuse3
Multiple Myeloma3
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.